Navigation Links
Solazyme Announces New Senior Vice President of Business Development
Date:10/3/2007

Troy J. Campione, Ph.D., Joins Solazyme Executive Team

SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire/ -- Solazyme, a bioscience company pioneering biofuels and health/wellness products from microalgae, has named Troy J. Campione, Ph.D., to the position of senior vice president of business development.

Campione will lead the development, negotiation, and finalization of partnership agreements and contracts with major companies. These deals will help fund research and development programs leveraging Solazyme's work on biofuels and industrial chemicals.

Campione has extensive experience monetizing technology across diverse industries and geographies. Most recently he was general manager and vice president of Symyx Technologies, Inc., a company providing high throughput research and informatics technologies globally to the chemical, energy, polymer, pharmaceutical, and electronics industries. At Symyx, he was accountable for collaborative research, strategic alliances, and materials licensing. During his tenure, Campione leveraged the company's technology position to negotiate more than $400 million of new research services, products, and licensing revenues with major chemical and energy companies including ExxonMobil, Dow Chemical, BP, Ineos, Innovene, and Celanese.

"Troy's breadth of experience in developing strategic alliances along with his talent for licensing technologies will enhance our ability to develop relationships with potential partners as we commercialize our algal-based technologies," said Jonathan Wolfson, president and chief operating officer of Solazyme. "We are extremely excited to have him join our management team."

Prior to Symyx, Campione spent 15 years at ExxonMobil in business, research and development, and technology management positions in Houston, Baytown, and Baton Rouge. He led the research and development activities for advanced catalyst and process technologies as worldwide basic chemicals technology manager, delivered continued success and growth of the vinyl intermediates area as its business manager, and prioritized, championed, and secured significant chemical plant expansions for the intermediates business of Exxon Chemical.

Campione earned his Ph.D. in chemical engineering from the University of Texas at Austin and also holds M.E. and B.S degrees in Chemical Engineering from Tulane University.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website: http://www.solazyme.com.

For More Information Contact:

Jackie Kolek Ellen Snook

Peppercom Peppercom

212-931-6166 415-438-9821

jkolek@peppercom.com esnook@peppercom.com


'/>"/>
SOURCE Solazyme
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, ... viscous and elastic characteristics when deformed, which is identical to how the human ... absorb compressive forces and return to its natural state along a hysteresis curve, ...
(Date:3/23/2017)... 2017  SeraCare Life Sciences, Inc., a manufacturer ... diagnostics manufacturers and clinical laboratories, is announcing ... Inherited Cancer reference material for ... sequencing (NGS). The Seraseq™ Inherited Cancer DNA Mix ... industry experts to validate the ability of ...
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
Breaking Biology Technology:
(Date:3/9/2017)... , March 9, 2017 4Dx has ... World Lung Imaging Workshop at the University of Pennsylvania. ... invited to deliver the latest data to world leaders ... event brings together leaders at the forefront of the ... lung imaging. "The quality of the ...
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , ... software globally, announces significant enhancements to new and core ... 2016. New products include mobile and desktop Acuant FRM ... TM - a real time manual review of ... idScan® technology provides the fastest and most accurate capture ...
Breaking Biology News(10 mins):